It turned out that pathways were enriched in cell division, inflammatory response, cytokine-cytokine receptor interaction, RNA metabolism, and transcriptional misregulation, specifically P53, MAPK4/6, NOTCH, and MYC pathways, which are critical regulators involved in myeloma initiation and progression. This evidence concerns the gene TP53 and plasma cell myeloma.